ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo

ClinicalTrials.gov ID: NCT03097861

Public ClinicalTrials.gov record NCT03097861. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo, in Adult Subjects With Chronic Idiopathic Constipation

Study identification

NCT ID
NCT03097861
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sucampo Pharma Americas, LLC
Industry
Enrollment
552 participants

Conditions and interventions

Interventions

  • Lubiprostone Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 12, 2017
Primary completion
Aug 16, 2017
Completion
Aug 16, 2017
Last update posted
Jan 13, 2020

2017

United States locations

U.S. sites
67
U.S. states
24
U.S. cities
61
Facility City State ZIP Site status
Investigative Site Birmingham Alabama 35216
Investigative Site Foley Alabama 36535
Investigative Site Little Rock Arkansas 72212
Investigative Site Anaheim California 92805
Investigative Sitee Chula Vista California 91910
Investigative Site Garden Grove California 92840
Investigative Site Long Beach California 90806
Investigative Site Los Angeles California 90057
Investigative Site Panorama City California 91402
Investigative Site San Diego California 92103
Investigative Site San Marcos California 92078
Investigative Site Upland California 91786
Investigative Site Colorado Springs Colorado 80909
Investigative Site New London Connecticut 06320
Investigative Site Clearwater Florida 33765
Investigative Site Coral Springs Florida 33065
Investigative Site DeLand Florida 32720
Investigative Site Hialeah Florida 33012
Investigative Site Jupiter Florida 33458
Investigative Site Miami Florida 33142
Investigative Site 2 Miami Florida 33143
Investigative Site Miami Florida 33143
Investigative Site Miami Florida 33165
Investigative Site Orlando Florida 32806
Investigative Site Plantation Florida 33322
Investigative Sitee Port Orange Florida 32129
Investigative Site Port Saint Lucie Florida 34952
Investigative Site Tampa Florida 33609
Investigative Site Tampa Florida 33634
Investigative Site West Palm Beach Florida 33409
Investigative Site Athens Georgia 30607
Investigative Site Snellville Georgia 30078
Investigative Site Stockbridge Georgia 30281
Investigative Site Blackfoot Idaho 83221
Investigative Site Boise Idaho 83712
Investigative Site Meridian Idaho 83642
Investigative Site Lake Charles Louisiana 70601
Investigative Site New Orleans Louisiana 70124
Investigative Site Shreveport Louisiana 71101
Investigative Site Chevy Chase Maryland 20815
Investigative Site Hagerstown Maryland 21742
Investigative Site New Bedford Massachusetts 02740
Investigative Site Jackson Missouri 39202
Investigative Sitee Bellevue Nebraska 68005
Investigative Site Las Vegas Nevada 89119
Investigative Site The Bronx New York 10459
Investigative Sitee High Point North Carolina 27262
Investigative Site Raleigh North Carolina 27612
Investigative Site Cleveland Ohio 44122
Investigative Site Mentor Ohio 44060
Investigative Site Midwest City Oklahoma 73110
Investigative Site Philadelphia Pennsylvania 19152
Investigative Site Charleston South Carolina 29406
Investigative Site Spartanburg South Carolina 29303
Investigative Site Chattanooga Tennessee 37421
Investigative Site 2 Jackson Tennessee 38305
Investigative Site Jackson Tennessee 38305
Investigative Site Houston Texas 77058
Investigative Site Houston Texas 77099
Investigative Site Longview Texas 75605
Investigative Site McAllen Texas 78504
Investigative Site Sugar Land Texas 77479
Investigative Site Layton Utah 84041
Investigative Site Taylorsville Utah 84123
Investigative Site West Jordan Utah 84088
Investigative Site Newport News Virginia 23606
Investigative Site Richmond Virginia 23220

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03097861, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2020 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03097861 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →